Profile: Diamics, Inc. is a molecular-based medical technology. We develop, manufacture and market proprietary systems for cervical cancer screening. Our product area includes clinical and patient. Our clinic includes testing methodologies. Our patient includes cervical cancer. The testing includes PAP testing, HPV testing and molecular approach. The pap test reduces the incidence of invasive cervical cancer for women who are screened on a regular basis. The molecular mechanism of HPV infection and transformation is the case for viruses are capable of cellular transformation. The molecular approach is based on looking for the actual changes in gene expression that are manifest in pre-neoplastic & neoplastic lesions of the cervix. Certain types of the human papillomavirus (HPV) have been found to be the cause of cervical cancer. HPV is one of the common sexually transmitted infections among men and women.

AMEX:IMA (SEC Filings)